Hepion Pharmaceuticals HEPA
OTC HEPA
$0.10 -0.04 (-28.57%)
At close: Nov 13, 2026 · 4:00 PM EST

Hepion Pharmaceuticals (HEPA) Gains from Sales and Divestitures (2018)

Updated

Hepion Pharmaceuticals' Gains from Sales and Divestitures came in at -$4,474 for FY2018.

Analysis

Hepion Pharmaceuticals (HEPA) Gains from Sales and Divestitures (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Hepion Pharmaceuticals 1.62 Mn -6.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -4,474.00
API Access

Hepion Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HEPA&period=max&api_key=YOUR_API_KEY